- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
CLARIVATE PLC (CLVT)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $4.61
1 Year Target Price $4.61
| 3 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -62.42% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.33B USD | Price to earnings Ratio - | 1Y Target Price 4.61 |
Price to earnings Ratio - | 1Y Target Price 4.61 | ||
Volume (30-day avg) 10 | Beta 1.51 | 52 Weeks Range 3.04 - 5.74 | Updated Date 01/9/2026 |
52 Weeks Range 3.04 - 5.74 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.57 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -15.83% | Operating Margin (TTM) 7.17% |
Management Effectiveness
Return on Assets (TTM) 0.99% | Return on Equity (TTM) -7.6% |
Valuation
Trailing PE - | Forward PE 5.3 | Enterprise Value 6456279689 | Price to Sales(TTM) 0.93 |
Enterprise Value 6456279689 | Price to Sales(TTM) 0.93 | ||
Enterprise Value to Revenue 2.58 | Enterprise Value to EBITDA 8.94 | Shares Outstanding 661435069 | Shares Floating 386595569 |
Shares Outstanding 661435069 | Shares Floating 386595569 | ||
Percent Insiders 16.97 | Percent Institutions 89.55 |
Upturn AI SWOT
CLARIVATE PLC

Company Overview
History and Background
Clarivate Plc (CLVT) was formed in 2016 as a spin-off from Thomson Reuters, initially focusing on providing data and analytics for intellectual property, scientific research, and market intelligence. It became a public company in 2019 through a SPAC merger with Churchill Capital Corp II. The company has since undergone strategic acquisitions to expand its offerings and market reach, aiming to become a leader in information services.
Core Business Areas
- Intelligent Data Solutions: This segment provides data and analytics to help organizations make informed decisions in areas like scientific research, intellectual property, and regulatory compliance. It includes solutions for patent analysis, trademark protection, and research discovery.
- Customer Management and Loyalty: This segment offers solutions for customer engagement, loyalty programs, and marketing analytics, helping businesses understand and interact with their customer base. Products include customer data platforms and loyalty management software.
- Product Lifecycle and Regulatory Solutions: This area focuses on providing data, software, and services to manage product development, regulatory affairs, and market access for life sciences and other regulated industries.
Leadership and Structure
Clarivate Plc is led by a management team with significant experience in data, analytics, and technology services. The organizational structure is aligned around its core business segments, with a focus on integrating acquired companies and technologies to drive synergistic growth. The company operates globally, with a distributed workforce and a centralized corporate structure.
Top Products and Market Share
Key Offerings
- Derwent Innovation: A leading platform for patent intelligence and analytics, offering tools for searching, analyzing, and managing patent data. Competitors include LexisNexis IP, Questel Orbit, and PatSnap. Market share data is not publicly disclosed but is considered a significant player in the IP analytics space.
- Web of Science: A comprehensive citation index and research discovery platform used by academic and research institutions worldwide. Competitors include Scopus (Elsevier), Google Scholar, and Dimensions.ai. It's a foundational product with a strong established user base in academia.
- Cortellis: A suite of solutions for the life sciences industry, providing data and analytics for drug discovery, clinical trials, and regulatory intelligence. Competitors include Informa Pharma Intelligence, Evaluate Pharma, and GlobalData. This is a key offering in a specialized but lucrative market.
Market Dynamics
Industry Overview
Clarivate operates in the information services, data analytics, and software sectors, serving industries like life sciences, intellectual property, academia, and marketing. This market is characterized by a growing demand for data-driven insights, digital transformation, and specialized industry knowledge. The industry is competitive, with a mix of large, diversified players and niche specialists.
Positioning
Clarivate is positioned as a provider of critical data, analytics, and workflow solutions that enable innovation and informed decision-making across its target markets. Its competitive advantages lie in its extensive proprietary datasets, deep domain expertise in areas like IP and life sciences, and a recurring revenue model through its subscription-based services. The company leverages its acquisitions to enhance its capabilities and expand its market footprint.
Total Addressable Market (TAM)
The TAM for information services, data analytics, and specialized software is in the hundreds of billions of dollars globally, encompassing various segments like IP intelligence, scientific research solutions, market intelligence, and customer management. Clarivate, through its diversified offerings and strategic acquisitions, aims to capture a significant share of these markets, particularly in its core areas of focus.
Upturn SWOT Analysis
Strengths
- Strong proprietary data assets and intellectual property.
- Established brands and loyal customer base in key segments (e.g., Web of Science, Derwent).
- Recurring revenue model from subscription-based services.
- Expertise in specialized domains like IP and life sciences.
- Global reach and diverse customer base.
Weaknesses
- Integration challenges from multiple acquisitions.
- Potential for market disruption by agile tech startups.
- Dependence on acquisitions for growth.
- Complex organizational structure due to acquisitions.
- Need for continuous investment in technology and data modernization.
Opportunities
- Expansion into emerging markets and new geographies.
- Leveraging AI and machine learning to enhance data analytics capabilities.
- Cross-selling and up-selling opportunities within its expanded customer base.
- Growth in the demand for regulatory and compliance solutions.
- Partnerships and collaborations to broaden reach and offerings.
Threats
- Intensifying competition from established players and new entrants.
- Data privacy regulations and cybersecurity risks.
- Economic downturns affecting customer spending.
- Technological obsolescence and the need for rapid innovation.
- Potential for unfavorable pricing pressures.
Competitors and Market Share
Key Competitors
- RELX PLC (RLX)
- Thomson Reuters (TRI)
- Elsevier (part of RELX)
- S&P Global (SPGI)
- Moody's Corporation (MCO)
Competitive Landscape
Clarivate competes in a fragmented but consolidating market. Its advantages include specialized data sets and established user bases. However, it faces intense competition from larger, diversified information providers like RELX and Thomson Reuters, which have broader reach and deeper pockets. Clarivate's ability to integrate acquisitions and deliver tangible synergies is crucial for its competitive standing.
Major Acquisitions
ProQuest
- Year: 2022
- Acquisition Price (USD millions): 4500
- Strategic Rationale: To significantly expand Clarivate's offerings in academic research, library solutions, and data analytics, creating a more comprehensive content and workflow platform.
Omniscien
- Year: 2021
- Acquisition Price (USD millions): 200
- Strategic Rationale: To enhance Clarivate's capabilities in life sciences intelligence and data analytics, particularly in areas related to drug discovery and development.
Growth Trajectory and Initiatives
Historical Growth: Clarivate has demonstrated growth, largely fueled by its strategy of acquiring complementary businesses. Organic growth has also been a focus, particularly in its core data and analytics segments. The company has aimed to integrate acquired entities to create cross-selling opportunities and operational synergies.
Future Projections: Analyst projections for Clarivate's future growth often center on its ability to achieve synergies from recent acquisitions, expand its subscription base, and capitalize on the increasing demand for data analytics in its key markets. Projections typically involve revenue growth and improvements in profitability as integration efforts mature.
Recent Initiatives: Recent initiatives have included significant acquisitions to bolster its offerings in areas such as customer loyalty and regulatory solutions, as well as efforts to streamline operations and enhance technological capabilities. The company is also focused on optimizing its product portfolio and improving customer experience across its platforms.
Summary
Clarivate Plc is a significant player in the data and analytics sector, with strong positions in intellectual property and scientific research. Its growth strategy heavily relies on acquisitions, which have expanded its portfolio but also introduced integration challenges and debt. The company benefits from recurring revenue streams and specialized domain expertise. However, it faces intense competition and needs to continuously innovate and effectively integrate its acquired assets to sustain growth and improve profitability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (e.g., 10-K, 10-Q)
- Financial News Outlets (e.g., Bloomberg, Reuters, Wall Street Journal)
- Industry Research Reports
- Company Website
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data may be subject to change and interpretation. Market share figures are estimates and may vary depending on the source and methodology.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com | ||
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

